Intelligence Platform
Patents
Browse 565 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8829187
Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
granted patentUS 8829025
Anti-cancer compounds
granted patentUS 8821922
Compositions and methods for polymer-caged liposomes
granted patentUS 8796022
Generation of functional basal forebrain cholinergic neurons from stem cells
granted patentUS 8791233
Maspin-based peptides and methods of use thereof
granted patentUS 8791116
Myosin light chain kinase inhibitor compounds, compositions and related methods of use
granted patentUS 8784895
Multifunctional metal nanoparticles having a polydopamine-based surface and methods of mak
granted patentUS 8758796
Functionalizing implantable devices with a poly (diol citrate) polymer
granted patentUS 8754044
Neuroprotection by hepatic cells and hepatocyte secretory factors
granted patentUS 8748569
Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav pept
granted patentUS 8742141
Inhibition and treatment of prostate cancer metastasis
granted patentUS 8734786
Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection
granted patentUS 8735075
Cancer screening by detection of ultrastructural and molecular markers
granted patentUS 8722939
Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis
granted patentUS 8710032
Inhibitors of the mevalonate pathway of Streptococcus pneumoniae
granted patentUS 8709444
Live-attenuated compositions for bacterial infections
granted patentUS 8697076
Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligome
granted patentUS 8697048
Peptide amphiphile suspension to prevent or reduce tumor formation from administered embry
granted patentUS 8685538
Stable polyelectrolyte coated nanoparticles
granted patentUS 8686041
Inhibition of ornithine aminotransferase for the treatment of proliferative disorders
granted patentUS 8673843
NMDA receptors modulators and uses thereof
granted patentUS 8586044
Treatment of chronic pelvic pain syndrome
granted patentUS 8580923
Self-assembling peptide amphiphiles and related methods for growth factor delivery
granted patentUS 8580231
Compositions and methods comprising magnetic resonance contrast agents
granted